$XBIT
XBiotech Inc.

2020 Q3 Form 10-Q Financial Statement

#000117184320005794 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $10.55M $15.50M
YoY Change
Cost Of Revenue $9.426M $13.20M $0.00
YoY Change
Gross Profit $1.123M $2.297M $0.00
YoY Change
Gross Profit Margin 10.65% 14.82%
Selling, General & Admin $3.450M $6.250M $1.310M
YoY Change 118.35% 377.1% -21.56%
% of Gross Profit 307.21% 272.09%
Research & Development $2.346M $2.565M $4.693M
YoY Change -48.25% -45.34% 18.84%
% of Gross Profit 208.9% 111.67%
Depreciation & Amortization $550.0K $540.0K $600.0K
YoY Change -8.33% -10.0% -1.64%
% of Gross Profit 48.98% 23.51%
Operating Expenses $5.793M $8.811M $6.006M
YoY Change -5.2% 46.7% 6.85%
Operating Profit -$4.670M -$6.514M -$6.006M
YoY Change -23.58% 8.46% 6.85%
Interest Expense $1.480M -$160.0K $150.0K
YoY Change -3800.0% -206.67% -151.72%
% of Operating Profit
Other Income/Expense, Net $1.476M -$662.0K $154.0K
YoY Change -3884.62% -529.87% -153.85%
Pretax Income -$3.194M -$7.176M -$5.852M
YoY Change -48.07% 22.62% -0.98%
Income Tax -$668.0K -$332.0K $0.00
% Of Pretax Income
Net Earnings -$2.526M -$6.844M -$5.852M
YoY Change -58.93% 16.95% -0.93%
Net Earnings / Revenue -23.95% -44.16%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$87.12K -$237.0K -$0.16
COMMON SHARES
Basic Shares Outstanding 28.99M 28.85M 36.11M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.4M $229.7M $44.90M
YoY Change 491.56% 411.58% 81.05%
Cash & Equivalents $238.4M $229.7M $44.92M
Short-Term Investments
Other Short-Term Assets $1.000M $3.000M $700.0K
YoY Change 66.67% 328.57% -22.22%
Inventory
Prepaid Expenses
Receivables $6.062M $20.68M
Other Receivables $6.100M $5.000M
Total Short-Term Assets $251.7M $258.4M $45.60M
YoY Change 515.2% 466.65% 76.97%
LONG-TERM ASSETS
Property, Plant & Equipment $26.21M $24.88M $26.28M
YoY Change 1.85% -5.31% -7.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $400.0K
YoY Change
Total Long-Term Assets $101.7M $100.4M $26.28M
YoY Change 295.26% 281.99% -7.88%
TOTAL ASSETS
Total Short-Term Assets $251.7M $258.4M $45.60M
Total Long-Term Assets $101.7M $100.4M $26.28M
Total Assets $353.4M $358.8M $71.88M
YoY Change 430.28% 399.15% 32.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.870M $5.240M $1.550M
YoY Change 264.75% 238.06% 6.53%
Accrued Expenses $2.306M $4.831M $912.0K
YoY Change 140.21% 429.71% -29.9%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.198M $14.14M $2.462M
YoY Change 206.68% 474.17% -10.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.100M $1.100M $0.00
YoY Change
Total Long-Term Liabilities $1.100M $1.100M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.198M $14.14M $2.462M
Total Long-Term Liabilities $1.100M $1.100M $0.00
Total Liabilities $7.254M $15.19M $2.462M
YoY Change 258.93% 517.06% -11.05%
SHAREHOLDERS EQUITY
Retained Earnings $94.79M $97.31M -$249.4M
YoY Change -137.09% -139.02% 10.1%
Common Stock $251.8M $246.4M $319.0M
YoY Change -21.35% -22.77% 14.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $346.1M $343.6M $69.41M
YoY Change
Total Liabilities & Shareholders Equity $353.4M $358.8M $71.88M
YoY Change 430.28% 399.15% 32.39%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$2.526M -$6.844M -$5.852M
YoY Change -58.93% 16.95% -0.93%
Depreciation, Depletion And Amortization $550.0K $540.0K $600.0K
YoY Change -8.33% -10.0% -1.64%
Cash From Operating Activities $7.480M -$11.57M -$4.860M
YoY Change -250.2% 138.07% 24.62%
INVESTING ACTIVITIES
Capital Expenditures -$690.0K -$430.0K -$30.00K
YoY Change 331.25% 1333.33% -40.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$690.0K -$430.0K -$30.00K
YoY Change 331.25% 1333.33% -40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.230M 280.0K 37.90M
YoY Change 696.43% -99.26%
NET CHANGE
Cash From Operating Activities 7.480M -11.57M -4.860M
Cash From Investing Activities -690.0K -430.0K -30.00K
Cash From Financing Activities 2.230M 280.0K 37.90M
Net Change In Cash 9.020M -11.72M 33.01M
YoY Change -285.6% -135.5% -935.7%
FREE CASH FLOW
Cash From Operating Activities $7.480M -$11.57M -$4.860M
Capital Expenditures -$690.0K -$430.0K -$30.00K
Free Cash Flow $8.170M -$11.14M -$4.830M
YoY Change -269.5% 130.64% 25.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28989172
CY2020Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2019 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2019 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28897394
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41519633
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
229703000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
714594000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20679000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2020Q2 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
2230000 USD
CY2019Q4 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
0 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4975000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
802000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1669000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
258389000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
716263000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24882000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25171000 USD
CY2020Q2 xbit Escrow Receivable
EscrowReceivable
75048000 USD
CY2019Q4 xbit Escrow Receivable
EscrowReceivable
75000000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
443000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
443000 USD
CY2020Q2 us-gaap Assets
Assets
358762000 USD
CY2019Q4 us-gaap Assets
Assets
816877000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5240000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2149000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4831000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4180000 USD
CY2020Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
1500000 USD
CY2019Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
0 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4500000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2565000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
49361000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14136000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60190000 USD
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1056000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1056000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
15192000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
61246000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
430929000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
343570000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
755631000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
358762000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816877000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15498000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28179000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
246395000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
324808000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-137000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-106000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
97312000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13201000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22875000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
2297000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
5304000 USD
us-gaap Gross Profit
GrossProfit
0 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2565000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4693000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3720000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9220000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6246000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1313000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10269000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2591000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
8811000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
6006000 USD
us-gaap Operating Expenses
OperatingExpenses
13989000 USD
us-gaap Operating Expenses
OperatingExpenses
11811000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6514000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6006000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8685000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11811000 USD
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
306000 USD
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
51000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
2204000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
129000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-503000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-503000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-465000 USD
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
102000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-558000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-44000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-662000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
154000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1143000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
95000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7176000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5852000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7542000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-332000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11716000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36752820
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6844000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-684000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6844000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5852000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6858000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11716000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28856085
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37519697
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32512789
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5852000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6858000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11716000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-121000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-99000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
39000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6965000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5951000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6889000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11677000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
347082000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6844000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-121000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
339000 USD
CY2020Q2 xbit Common Stock Share Subscribed Value Issuance
CommonStockShareSubscribedValueIssuance
-62000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3176000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
343570000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
36983000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5852000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-99000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37497000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
296000 USD
CY2019Q2 xbit Adjustments To Additional Paid In Capital Collection Of Stock Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCollectionOfStockSubscriptionReceivable
102000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
486000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
69413000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
755631000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6858000 USD
xbit Shares Buyback Equity Impact Amount
SharesBuybackEquityImpactAmount
-420000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8258000 USD
xbit Adjustments To Additional Paid In Capital Collection Of Stock Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCollectionOfStockSubscriptionReceivable
-62000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6631000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
343570000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
41398000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11716000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
39000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37497000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1056000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
837000 USD
xbit Adjustments To Additional Paid In Capital Collection Of Stock Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCollectionOfStockSubscriptionReceivable
302000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
69413000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-6858000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11716000 USD
us-gaap Depreciation
Depreciation
1104000 USD
us-gaap Depreciation
Depreciation
1199000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6631000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1056000 USD
xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
2230000 USD
xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20679000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4975000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 USD
xbit Amount Held In Escrow
AmountHeldInEscrow
-48000 USD
xbit Amount Held In Escrow
AmountHeldInEscrow
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-868000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-515000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3091000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-212000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
651000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-379000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4500000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1500000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-46796000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72241000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9540000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
815000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-815000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37000 USD
xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
-420000000 USD
xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
37497000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8258000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
837000 USD
xbit Subscription Receivable
SubscriptionReceivable
62000 USD
xbit Subscription Receivable
SubscriptionReceivable
-0 USD
xbit Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
0 USD
xbit Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
302000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-411804000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38636000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-484891000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29098000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
714594000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15823000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
229703000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44921000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
109000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
229700000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.91 pure
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6631000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1056000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.88 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Use of Estimates </b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 30.6pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported values of amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3175000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
486000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.02
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.88
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.99
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Concentrations of Credit Risk </b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 30.6pt;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents. The Company holds these investments in highly-rated financial institutions, and limits the amounts of credit exposure to any <em style="font: inherit;">one</em> financial institution. These amounts at times <em style="font: inherit;"> may </em>exceed federally insured limits. The Company has <em style="font: inherit;">not</em> experienced any credit losses in such accounts and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on these funds. The Company has <em style="font: inherit;">no</em> off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24882000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25171000 USD
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
771000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3800000 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
420000000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14000000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 xbit Stock Repurchased During Period Price Per Share
StockRepurchasedDuringPeriodPricePerShare
30
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
420000000 USD
CY2020Q1 xbit Percentage Of Outstanding Shares Repurchased
PercentageOfOutstandingSharesRepurchased
0.3267 pure
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1400000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8300000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6965730
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
81500
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1377761
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42042
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5627427
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10500000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M20D
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6844000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5852000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6858000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11716000 USD
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28856085
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37519697
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32512789
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36752820
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-332000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.046 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.091 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-684000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.091 pure

Files In Submission

Name View Source Status
0001171843-20-005794-index-headers.html Edgar Link pending
0001171843-20-005794-index.html Edgar Link pending
0001171843-20-005794.txt Edgar Link pending
0001171843-20-005794-xbrl.zip Edgar Link pending
ex_197741.htm Edgar Link pending
ex_197742.htm Edgar Link pending
ex_197743.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xbit-20200630.xsd Edgar Link pending
xbit-20200630_cal.xml Edgar Link unprocessable
xbit-20200630_def.xml Edgar Link unprocessable
xbit-20200630_lab.xml Edgar Link unprocessable
xbit-20200630_pre.xml Edgar Link unprocessable
xbit20200630_10q.htm Edgar Link pending
xbit20200630_10q_htm.xml Edgar Link completed